Drug intelligence / Profile preview

(S)-AMPA

Development stage
Unknown
Lead developer
Servier
Modality
Small Molecules
01

Overview

(S)-AMPA is the active enantiomer of AMPA, a synthetic non-proteinogenic alpha-amino acid and potent, selective agonist for the AMPA subtype of ionotropic glutamate receptors. It mimics the action of glutamate at these receptors, inducing fast excitatory postsynaptic potentials by activating non-selective cation channels permeable to sodium and potassium ions. This compound is widely used as an experimental tool in neuroscience research to study synaptic transmission and receptor pharmacology. The R-enantiomer is virtually inactive at these sites. Its primary use is in laboratory research; it has no approved therapeutic indications[1][4][6][8].

Other names
(S)-alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid(2S)-2-amino-3-(3-hydroxy-5-methyl-1,2-oxazol-4-yl)propanoic acidalpha-Amino-3-hydroxy-5-methylisoxazolepropionic acidalpha-Amino3-hydroxy-5-methylisoxazolepropionic acidalpha-Amino 3-hydroxy-5-methylisoxazolepropionic acidglutamate-AMPA
02

Targets

GRIA1 (AMPA receptor subunit GluA1)GRIA2 (AMPA receptor subunit GluA2)GRIA3 (AMPA receptor subunit GluA3)GRIA4 (AMPA receptor subunit GluA4)GRM3 (mGluR3)GRM4 (mGluR4)

Beyond the preview

Go deeper on (S)-AMPA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on (S)-AMPA.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call